SELECTIVE OX1R ANTAGONIST IN NICOTINE DEPENDENCE INDUCED WITHDRAWAL SYNDROME IN MICE

The present invention relates to the field of pharmaceuticals. 5 Specifically, thepresent invention relates to a compound that attenuates nicotine dependenceinduced withdrawal syndrome. The present invention further relates to acompound that is for the treatment and management of nicotine addiction,wherein the compound is a selective Oxerin receptor antagonist.

Inventors

Thakur Gurjeet Singh, Amarjot Kaur Grewal, Sonia Dhiman

Patent File Number - 202011053497        Patent File Date - 09/12/2020